Targeting farnesylation as a novel therapeutic approach in HRAS-mutant rhabdomyosarcoma
Patience Odeniyide(Johns Hopkins University), Christine A. Pratilas(Johns Hopkins University)
Cited by 41
Related Papers
CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors
|Science Advances|2023|26
CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon restoration of RB function in malignant peripheral nerve sheath tumors
|bioRxiv (Cold Spring Harbor Laboratory)|2023|5